Locus control region of the human CD2 gene in a lentivirus vector confers position-independent transgene expression.
Vectors derived from murine leukemia virus (MLV) have been used in many human gene therapy clinical trials. However, insertion of the locus control regions (LCRs) derived from the beta-globin gene locus or the CD2 gene into MLV vectors frequently led to vector rearrangement. Since the human immunodeficiency virus (HIV) sequence diverges significantly from the MLV sequence, we tested whether the LCR sequence is more stable in the context of an HIV vector. Clones derived from human fibrosarcoma line HT1080 cells transduced with an HIV vector containing the T-cell-specific CD2 LCR exhibit the same wide range of transgene expression as clones lacking the LCR. In contrast, Jurkat and primary T-cell clones derived from the transduction of the LCR-containing vector show, on average, a three- to fourfold increase in transgene expression relative to that of the control vector. This is consistent with previous observations that the CD2 LCR contains a T-cell-specific enhancer. In addition, the clones derived from the LCR-containing vector have a much lower clonal variation in transgene expression than those derived from the control vector. We also demonstrate that the level of transgene expression is proportional to the vector copy number. These results suggest that the human CD2 LCR sequence is compatible with HIV vector sequences and confers enhanced integration site-independent and copy number-dependent expression of the transgene. Thus, HIV vectors may represent the ideal vehicle to deliver genes controlled by various cis-acting elements such as LCRs.
Kowolik
C M
CM
Department of Virology, Beckman Research Institute, City of Hope, Duarte, California, USA.
Hu
J
J
Yee
J K
JK
D018801:CD2 Antigens / Q000235:genetics*; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D018628:Gene Dosage; D015870:Gene Expression; D005822:Genetic Vectors / Q000235:genetics*; D005914:Globins / Q000235:genetics; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D019169:Jurkat Cells; D019901:Locus Control Region; D019076:Transgenes; D014407:Tumor Cells, Cultured
D018801:CD2 Antigens; D005914:Globins